MIRO - Miromatrix Medical Inc.
Close
3.39
0.020 0.590%
Share volume: 0
Last Updated: Tue 12 Dec 2023 10:00:00 PM CET
Biological Product (except Diagnostic) Manufacturing :
-4.32%
PREVIOUS CLOSE
CHG
CHG%
$3.37
0.02
0.59%
Fundamental analysis
18%
Profitability
0%
Dept financing
25%
Liquidity
75%
Performance
20%
Performance
5 Days
0 0%
1 Month
0 0%
3 Months
0 0%
6 Months
0 0%
1 Year
0 0%
2 Year
0 0%
Key data
Company detail
CEO: Jeff Ross
Region: US
Website: miromatrix.com
Employees: 60
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Biological Product (except Diagnostic) Manufacturing
Sector: Manufacturing
Region: US
Website: miromatrix.com
Employees: 60
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Biological Product (except Diagnostic) Manufacturing
Sector: Manufacturing
Miromatrix Medical Inc. develops novel technology for bioengineering fully transplantable organs. The company has collaborations with The Mayo Clinic, Mount Sinai Hospital, and The Texas Heart Institute.
Recent news